Accountability for the Public Policy Contribution of Not-for-Profit Organizations: Who is Accountable to Whom, and for What?

2017 ◽  
pp. 49-66 ◽  
Author(s):  
Peter Wilkins ◽  
David Gilchrist
Keyword(s):  
Public Policy ◽  
The Public ◽  
For Profit ◽  
Not For Profit ◽  
Not For Profit Organizations ◽  
For Profit Organizations

scholarly journals Philanthropy Accountability

2016 ◽  
Vol 6 (2) ◽  
pp. 114
Author(s):  
Edy Sukarno
Keyword(s):  
Current Situation ◽  
Causal Factor ◽  
Precise Information ◽  
The Public ◽  
For Profit ◽  
Not For Profit ◽  
Other Information ◽  
Public Sectors ◽  
Not For Profit Organizations ◽  
For Profit Organizations

A causal factor of susceptibility of philanthropy in Indonesia which is now  facing turbulence era is a weak implemented accountability. Philanthropy is changing to self adjustment with the aspiration and demand of the public sectors. The changing management is needed by considering the current situation and condition, participation, and shall be supported by all of the stakeholders especially employees of not-for-profit organizations, in order to achieve the expected goal. The<br />principle of accountability requires philanthropy governance to make sure that disclosures of accurate and precise information shall be done in relation to the material consisting of financial terms and conditions, performance and leadership of the organization. The accountabilitiy is very important to prevent fraud in financial infomation and other information forwarded to not-for-profit organizations. This article is expected to provide particularly and important knowledge about the terms, functions and relationships between philanthropy accountability and information disclosures.

Partnership agreements for regenerative medicines: a database analysis and implications for future innovation

2021 ◽  
Author(s):  
Tingting Qiu ◽  
Yitong Wang ◽  
Shuyao Liang ◽  
Ru Han ◽  
Mondher Toumi
Keyword(s):  
Scientific Discovery ◽  
Biotechnology Company ◽  
Database Analysis ◽  
For Profit ◽  
Preclinical Phase ◽  
Not For Profit ◽  
Licensing Agreements ◽  
Regenerative Medicines ◽  
Not For Profit Organizations ◽  
For Profit Organizations

Aim: Partnerships have been leveraged to advance the regenerative medicines (RMs) development. This study analyzed the evolution of partnership landscape for regenerative medicines (RMs). Methods: Partnership agreements publicly announced from January 2014 – June 2020 were described. Results: 1169 partnership agreements with total amount of US$63,496 million were identified. Most agreements concerned RMs that were for oncology (25.3%), in the discovery or preclinical phase (66.9%) and gene-based products (45.3%). The most common partnership type is collaborative agreements without licensing. The partnerships between ‘Biotechnology company and not-for-profit organizations’ represented the largest number (n = 416; 35.6%). ‘Big Pharma’ preferred collaboration and licensing agreements with a higher amount. Conclusion: Collaborations between highly specialized players with complementary expertise promote the successful translation of scientific discovery to RMs.

Sign in / Sign up

Export Citation Format

Share Document